Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN151,82151,840,89
Msft1,59
Nokia9,539,5962,76
IBM1,04
Mercedes-Benz Group AG43,643,83-0,75
PFE0,29
22.09.2026 1:33:47
Indexy online
AD Index online
select
AD Index online
 

  • 18.09.2026
China Pharm (1093.HK, Hong Kong)
Závěr k 18.9.2026 Změna (%) Změna (HKD) Objem obchodů (HKD)
8,93 0,90 0,08 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 22.09.2026
Popis společnosti
Obecné informace
Název společnostiCSPC Pharmaceutical Group Ltd
Ticker1093
Kmenové akcie:Ordinary Shares
RIC1093.HK
ISINHK1093012172
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky30.06.2026
Počet zaměstnanců k 30.06.2026 18 626
Akcie v oběhu k 30.06.202611 522 451 732
MěnaCNY
Kontaktní informace
UliceNo.896 Zhongshandong Street
MěstoSHIJIAZHUANG
PSČ050035
ZeměChina
Kontatní osoba 
Funkce kontaktní osoby 
Telefon8631 187 037 015
Fax8631187039608

Business Summary: CSPC Pharmaceutical Group Ltd is a company primarily engaged in the production and sales of pharmaceuticals. The Company's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The Company's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The Company conducts its businesses in domestic and overseas markets.
Financial Summary: BRIEF: For the six months ended 30 June 2026, CSPC Pharmaceutical Group Ltd revenues increased 40% to RMB18.59B. Net income increased from RMB2.55B to RMB6.09B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Finance costs decrease of 38% to RMB13.3M (expense), Share of results of joint ventures increase from RMB1.9M to RMB6.7M (income).
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICSAll Other Miscellaneous Food Manufacturing
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)
NAICSOffices of Other Holding Companies
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Offices of Other Holding Companies
SICPharmaceutical Preparations
SICBiological Prod's Not Diagnostic
SICMedicinals And Botanicals
SICFood Preparations, Nec
SICCommercial Physical Research
SICHolding Companies, Nec
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 22.09.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardDong Chen Cai7227.05.202201.01.1998
Executive Vice Chairman of the Board, Chief Executive OfficerLei Cai4619.12.202519.12.2025
Executive Vice Chairman of the Board, Chief Operating OfficerQingjie Wei5619.12.202519.12.2025
Executive DirectorCuilong Zhang5719.12.202509.07.2018
Executive DirectorXin Cai3429.05.202429.05.2024
Executive DirectorWeiping Chen4606.12.202406.12.2024
Executive DirectorChunlei Li4912.12.201712.12.2017
Executive DirectorZhiyong Qu4421.11.202521.11.2025
Executive DirectorZhenguo Wang5621.05.201920.01.2012
Executive DirectorBing Yao4929.05.202429.05.2024